An Open-Label, Single-Dose Study to Assess the Pharmacokinetics of the Hydrocodone Bitartrate Extended-Release Tablet (45 mg) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment.

Trial Profile

An Open-Label, Single-Dose Study to Assess the Pharmacokinetics of the Hydrocodone Bitartrate Extended-Release Tablet (45 mg) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Hydrocodone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Cephalon
  • Most Recent Events

    • 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development.
    • 31 Dec 2011 Actual initiation date changed from Jan 2011 to Mar 2011 and actual patients number (55) added as reported by ClinicalTrials.gov.
    • 31 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top